Epirus Biopharmaceuticals Inc Stock Other OTC
Equities
US29428P1075
Biotechnology & Medical Research
Financials (USD)
Sales 2014 | 0 | Sales 2015 | 0.7 | Capitalization | 75.33M |
---|---|---|---|---|---|
Net income 2014 | -41M | Net income 2015 | -52M | EV / Sales 2014 | 14,770,294,750 x |
Net cash position 2014 | 14.18M | Net cash position 2015 | 16.68M | EV / Sales 2015 | 83,658,631 x |
P/E ratio 2014 |
-0.83
x | P/E ratio 2015 |
-1.35
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+2.60% | 42.75B | |
+47.70% | 41.61B | |
+12.06% | 41.34B | |
-8.83% | 26.59B | |
+7.72% | 25.49B | |
-22.78% | 18.12B | |
+30.94% | 12.24B | |
-1.71% | 11.76B | |
+9.50% | 11B |